Similar articles

• Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.

  Povoski SP, Zhou W, Longnecker DS, Bell RH Jr. Povoski SP, et al. Oncol Res. 1994;6(9):411-7. Oncol Res. 1994. PMID: 7703527
• The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.

  Bardeesy N, Sharpless NE, DePinho RA, Merlino G. Bardeesy N, et al. Semin Cancer Biol. 2001 Jun;11(3):201-18. doi: 10.1006/scbi.2000.0371. Semin Cancer Biol. 2001. PMID: 11407945 Review.
• Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice.

  Grippo PJ, Nowlin PS, Demeure MJ, Longnecker DS, Sandgren EP. Grippo PJ, et al. Cancer Res. 2003 May 1;63(9):2016-9. Cancer Res. 2003. PMID: 12727811
• The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.

  Lewis BC, Klimstra DS, Varmus HE. Lewis BC, et al. Genes Dev. 2003 Dec 15;17(24):3127-38. doi: 10.1101/gad.1140403. Epub 2003 Dec 17. Genes Dev. 2003. PMID: 14681205 Free PMC article.
• Models of Exocrine Pancreatic Neoplasms in Transgenic Mice.

  Longnecker DS. Longnecker DS. Comp Med. 2004 Feb;54(1):18-21. Comp Med. 2004. PMID: 15382335 Review. No abstract available.